Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 5 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 1 hour agoModerna has not said when the combination vaccine might be evaluated by the FDA. Both Pfizer-BioNTech and Novavax are studying combination vaccines to protect ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
AOL· 3 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for people aged 60 and older for the virus. RSV, which typically causes cold-like ...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via AOL· 7 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 6 days agoAn oncology sales boom ahead In late 2023, Pfizer acquired Seagen, which currently markets four...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
NBC 10 - FOX 14 Monroe· 5 days agoWASHINGTON (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID-19...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via Yahoo News· 2 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...